HIF1A and neoplasm: Based on a number of clinical studies, several investigators have promoted the view that the expression of HIF-1α and its target genes may be useful biomarkers of tumor hypoxia, aggressiveness, and radiation resistance in cervical carcinoma [16, 18, 19, 24, 25, 29, 30].